T1	Age 2 13	54-year-old
T2	Gender 14 20	female
T3	Activity 25 33	admitted
E1	Activity:T3 
T4	Other_entity 41 49	hospital
T5	Anatomical_structure 266 297	left descending coronary artery
T6	Other_entity 234 256	collateral circulation
R1	MODIFIER Arg1:T5 Arg2:T6	
T7	Medication 3751 3778	treatment with interferon-β
E2	Medication:T7 
T8	Lab 3656 3659	EMB
E3	Lab:T8 
R2	BEFORE Arg1:E3 Arg2:E2	
T9	Disease_disorder 85 87	HF
E4	Disease_disorder:T9 
T10	Disease_disorder 140 148	acute MI
E5	Disease_disorder:T10 
T11	Diagnostic_procedure 162 182	coronary angiography
E6	Diagnostic_procedure:T11 
T12	Diagnostic_procedure 434 443	Class III
E7	Diagnostic_procedure:T12 
T14	Lab 561 600	Nterminal-pro-brain natriuretic peptide
E9	Lab:T14 
T13	Quantitative_concept 613 624	10581 pg/mL
R3	MODIFIER Arg1:T13 Arg2:E9	
T17	Quantitative_concept 543 551	elevated
R4	MODIFIER Arg1:T17 Arg2:E9	
T15	Quantitative_concept 713 718	81 mm
T16	Lab 665 704	left ventricular end-diastolic diameter
E8	Lab:T16 
R5	MODIFIER Arg1:T15 Arg2:E8	
T18	Quantitative_concept 655 664	increased
R6	MODIFIER Arg1:T18 Arg2:E8	
T19	Lab 725 759	left ventricular ejection fraction
E10	Lab:T19 
T20	Quantitative_concept 767 770	25%
R7	MODIFIER Arg1:T20 Arg2:E10	
T21	Quantitative_concept 721 724	low
R8	MODIFIER Arg1:T21 Arg2:E10	
T23	Sign_symptom 852 870	global hypokinesis
E12	Sign_symptom:T23 
T24	Quantitative_concept 845 851	severe
R9	MODIFIER Arg1:T24 Arg2:E12	
T25	Sign_symptom 954 957	CAD
E13	Sign_symptom:T25 
T26	Sign_symptom 974 995	arterial hypertension
E14	Sign_symptom:T26 
T27	Sign_symptom 997 1018	hypercholesterolaemia
E15	Sign_symptom:T27 
T28	Sign_symptom 1020 1042	ventricular arrhythmia
E16	Sign_symptom:T28 
T29	Medication 1044 1054	carvedilol
E17	Medication:T29 
T30	Medication 1056 1064	ramipril
E18	Medication:T30 
T31	Medication 1066 1080	spironolactone
E19	Medication:T31 
T32	Medication 1082 1092	furosemide
E20	Medication:T32 
T33	Medication 1094 1106	atorvastatin
E21	Medication:T33 
T34	Medication 1108 1121	trimetazidine
E22	Medication:T34 
T35	Medication 1123 1130	aspirin
E23	Medication:T35 
T36	Time 1133 1149	Two months later
E24	Time:T36 
T37	Activity 1162 1171	admission
E25	Activity:T37 
T38	Other_entity 1179 1187	hospital
T39	Qualitative_concept 1223 1231	class II
T40	Lab 1218 1222	NYHA
E26	Lab:T40 
R10	MODIFIER Arg1:T39 Arg2:E26	
T41	Quantitative_concept 1208 1216	improved
R11	MODIFIER Arg1:T41 Arg2:E26	
T42	Quantitative_concept 1243 1253	1869 pg/mL
T43	Lab 1233 1242	NT-proBNP
E27	Lab:T43 
R12	MODIFIER Arg1:T42 Arg2:E27	
T44	Quantitative_concept 1261 1266	73 mm
T45	Lab 1255 1260	LVEDD
E28	Lab:T45 
R13	MODIFIER Arg1:T44 Arg2:E28	
R14	MODIFIER Arg1:T41 Arg2:E28	
R15	MODIFIER Arg1:T41 Arg2:E27	
T46	Quantitative_concept 1273 1276	35%
T47	Lab 1268 1272	LVEF
E29	Lab:T47 
R16	MODIFIER Arg1:T46 Arg2:E29	
R17	MODIFIER Arg1:T41 Arg2:E29	
T48	Sign_symptom 1336 1362	hypokinesis of other walls
E30	Sign_symptom:T48 
T49	Quantitative_concept 1327 1335	moderate
R18	MODIFIER Arg1:T49 Arg2:E30	
T50	Sign_symptom 1282 1322	inferior and inferolateral wall akinesis
E31	Sign_symptom:T50 
T51	Diagnostic_procedure 1365 1398	Cardiovascular magnetic resonance
E32	Diagnostic_procedure:T51 
T52	Sign_symptom 1445 1467	gadolinium enhancement
E33	Sign_symptom:T52 
T53	Time 1440 1444	late
E34	Time:T53 
R19	MODIFIER Arg1:E34 Arg2:E33	
T54	Anatomical_structure 1481 1493	inferoseptal
T55	Anatomical_structure 1506 1514	inferior
T56	Anatomical_structure 1537 1550	inferolateral
R20	MODIFIER Arg1:T54 Arg2:E33	
R21	MODIFIER Arg1:T55 Arg2:E33	
R22	MODIFIER Arg1:T56 Arg2:E33	
T22	Sign_symptom 777 785	akinesis
E11	Sign_symptom:T22 
T57	Anatomical_structure 793 801	inferior
T58	Anatomical_structure 803 815	inferoseptal
T59	Anatomical_structure 820 833	inferolateral
R23	MODIFIER Arg1:T57 Arg2:E11	
R24	MODIFIER Arg1:T58 Arg2:E11	
R25	MODIFIER Arg1:T59 Arg2:E11	
T60	Activity 1630 1638	observed
E35	Activity:T60 
T61	Sign_symptom 1639 1652	LV dilatation
E36	Sign_symptom:T61 
T62	Sign_symptom 1682 1685	LGE
E37	Sign_symptom:T62 
T63	Anatomical_structure 1709 1721	inferoseptal
T64	Anatomical_structure 1726 1734	inferior
T65	Lab 1805 1815	troponin I
E38	Lab:T65 
T66	Quantitative_concept 1817 1828	0.014 ng/mL
R26	MODIFIER Arg1:T66 Arg2:E38	
T67	Quantitative_concept 1779 1787	elevated
R27	MODIFIER Arg1:T67 Arg2:E38	
T68	Diagnostic_procedure 1831 1847	Echocardiography
E39	Diagnostic_procedure:T68 
T69	Sign_symptom 1887 1910	coronary artery changes
E40	Sign_symptom:T69 
T70	Sign_symptom 1915 1936	cardiac contractility
E41	Sign_symptom:T70 
R28	BEFORE Arg1:E40 Arg2:E39	
R29	BEFORE Arg1:E41 Arg2:E39	
T71	Diagnostic_procedure 2047 2068	endomyocardial biopsy
E42	Diagnostic_procedure:T71 
T72	Activity 2037 2044	perform
E43	Activity:T72 
*	OVERLAP E43 E42
T73	Sign_symptom 2352 2375	ultrastructural changes
E44	Sign_symptom:T73 
T74	Anatomical_structure 2413 2423	myofibrils
T75	Anatomical_structure 2425 2432	nucleus
T76	Anatomical_structure 2434 2447	mitochondrion
T77	Anatomical_structure 2449 2470	endoplasmic reticulum
R30	MODIFIER Arg1:T63 Arg2:E37	
R31	MODIFIER Arg1:T64 Arg2:E37	
T78	Therapeutic_procedure 2542 2544	HF
E45	Therapeutic_procedure:T78 
T79	Therapeutic_procedure 2549 2552	CAD
E46	Therapeutic_procedure:T79 
T80	Activity 2567 2579	administered
E47	Activity:T80 
T81	Qualitative_concept 2739 2748	Class III
T82	Lab 2734 2738	NYHA
E48	Lab:T82 
R32	MODIFIER Arg1:T81 Arg2:E48	
T83	Quantitative_concept 2760 2770	1980 pg/dL
T84	Lab 2750 2759	NT-proBNP
E49	Lab:T84 
R33	MODIFIER Arg1:T83 Arg2:E49	
T85	Quantitative_concept 2781 2788	3 ng/mL
T86	Lab 2772 2780	troponin
E50	Lab:T86 
R34	MODIFIER Arg1:T85 Arg2:E50	
T87	Quantitative_concept 2796 2801	77 mm
T88	Lab 2790 2795	LVEDD
E51	Lab:T88 
R35	MODIFIER Arg1:T87 Arg2:E51	
T89	Quantitative_concept 2808 2811	30%
T90	Lab 2803 2807	LVEF
E52	Lab:T90 
R36	MODIFIER Arg1:T89 Arg2:E52	
T91	Quantitative_concept 2813 2817	8048
T92	Sign_symptom 2818 2865	ventricular extrasystoles without complex forms
E53	Sign_symptom:T92 
R37	MODIFIER Arg1:T91 Arg2:E53	
T93	Duration 2869 2876	24-hour
E54	Duration:T93 
T94	Activity 2877 2898	Holter ECG monitoring
E55	Activity:T94 
R38	MODIFIER Arg1:E54 Arg2:E55	
T95	Quantitative_concept 3435 3442	62.5 μg
T96	Medication 3372 3384	interferon-β
E56	Medication:T96 
R39	MODIFIER Arg1:T95 Arg2:E56	
T97	Time 3460 3470	first week
E57	Time:T97 
R40	MODIFIER Arg1:E57 Arg2:T95	
T98	Quantitative_concept 3472 3478	125 μg
T99	Other_entity 461 487	New York Heart Association
T100	Other_event 2691 2705	rehospitalised
E58	Other_event:T100 
T101	Time 2656 2668	three months
E59	Time:T101 
R41	AFTER Arg1:E59 Arg2:E58	
T102	Time 3495 3517	second and third weeks
E60	Time:T102 
R42	MODIFIER Arg1:E60 Arg2:T98	
T103	Quantitative_concept 3523 3531	187.5 μg
T104	Qualitative_concept 3825 3832	class I
T105	Lab 3820 3824	NYHA
E61	Lab:T105 
R43	MODIFIER Arg1:T104 Arg2:E61	
T106	Quantitative_concept 3834 3843	NT-proBNP
T107	Lab 3844 3853	512 pg/mL
E62	Lab:T107 
T108	Lab 3855 3860	LVEDD
E63	Lab:T108 
T109	Quantitative_concept 3861 3866	68 mm
T110	Lab 3868 3872	LVEF
E64	Lab:T110 
T111	Quantitative_concept 3873 3876	45%
R44	MODIFIER Arg1:T111 Arg2:E64	
T112	Activity 4040 4049	follow-up
E65	Activity:T112 
T113	Other_entity 2615 2645	European Society of Cardiology
T114	Duration 3913 3920	24-hour
E66	Duration:T114 
T115	Frequency 3557 3572	every other day
E67	Frequency:T115 
T116	Time 3582 3614	fourth to the twenty-fourth week
E68	Time:T116 
T117	Activity 942 949	treated
E69	Activity:T117 
*	OVERLAP E13 E69 E14 E15 E16
T118	Activity 393 402	diagnosed
E70	Activity:T118 
T119	Anatomical_structure 207 228	right coronary artery
T120	Time 3625 3637	fourth month
E71	Time:T120 
T121	Activity 1405 1414	performed
E72	Activity:T121 
T122	Sign_symptom 627 646	cardiac enlargement
E73	Sign_symptom:T122 
T123	Diagnostic_procedure 3062 3109	real-time polymerase chain reaction examination
E74	Diagnostic_procedure:T123 
T124	Sign_symptom 3266 3285	presence of HEV RNA
E75	Sign_symptom:T124 
*	OVERLAP E75 E74
T125	Disease_disorder 3291 3311	viral cardiomyopathy
E76	Disease_disorder:T125 
T126	Activity 3316 3325	diagnosed
E77	Activity:T126 
*	OVERLAP E77 E76
T127	Activity 3947 3955	observed
E78	Activity:T127 
R45	AFTER Arg1:E4 Arg2:E5	
*	OVERLAP E70 E4
R46	AFTER Arg1:E69 Arg2:E12	
R47	AFTER Arg1:E24 Arg2:E23	
R48	AFTER Arg1:E59 Arg2:E47	
R49	AFTER Arg1:E65 Arg2:E78	
T128	Anatomical_structure 2472 2496	intercellular connection
T129	Anatomical_structure 2498 2511	blood vessels
T130	Activity 2531 2539	detected
E79	Activity:T130 
T131	Activity 3211 3222	Examination
E80	Activity:T131 
T132	Other_entity 3226 3242	frozen specimens
T133	Time 115 134	three years earlier
E81	Time:T133 
T134	Disease_disorder 2163 2175	myocytolysis
E82	Disease_disorder:T134 
T135	Disease_disorder 2180 2199	myocardial fibrosis
E83	Disease_disorder:T135 
